NCT06054178CompletedPhase 2
Identification of Nerves Using Fluorescein Sodium
Intraoperative Nerve Identification With Fluorescein Sodium
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 19 Sept 2023
- Start date
- 7 Nov 2024
- Primary completion date
- 22 May 2025
- Lead sponsor
- Stanford University
- NCT number
- NCT06054178
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 8
- From 7 Nov 2024 to the primary completion date, 22 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study
- History of adverse reaction to fluorescein including allergy.
- History of renal failure or chronic kidney disease
Other
- Inability or unwillingness of a subject
- Pregnancy
- Vulnerable or disadvantaged population (pregnant women, decisionally impaired, homeless, employees, students)
Who the study is looking for
- Male or female subjects
- 18 years or older
- Scheduled for open head and neck surgery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford Medical Center Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.